Clinical Trial Update: Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing levomilnacipran ER to adjunctive quetiapine for adults with inadequate relief from SSRIs in major depressive disorder completed; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Levomilnacipran ER (levomilnacipran hydrochloride)
• Quetiapine (quetiapine)

Snippet

Sponsor: Duke University | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-07-02